Amphastar Pharmaceuticals (AMPH) Revenue (2013 - 2026)
Amphastar Pharmaceuticals (AMPH) posted quarterly Revenue of $171.2 million for Q1 2026, little changed year-over-year from $170.5 million in Q1 2025, and down 6.52% quarter-over-quarter from $183.1 million in Q4 2025.
Amphastar Pharmaceuticals (AMPH) Revenue (2013 - 2026) Analysis & Trends
Amphastar Pharmaceuticals' Revenue history runs 14 years deep, the most recent figure standing at $171.2 million for Q1 2026.
- In Q1 2026, Revenue changed 0.38% year-over-year to $171.2 million; the TTM figure through Mar 2026 stood at $720.5 million (down 1.39% YoY), while the FY2025 annual figure was $719.9 million, down 1.65% from the prior year.
- Revenue for Q1 2026 stood at $171.2 million, down from $183.1 million in the prior quarter.
- The five-year high for Revenue was $191.8 million in Q3 2025, with the low at $120.1 million in Q3 2022.
- The 5-year median for Revenue is $171.8 million (2024), against an average of $162.7 million.
- The sharpest annual moves came in 2023 and 2025: Revenue surged 50.3% in 2023, then retreated 4.38% in 2025.
- Amphastar Pharmaceuticals' Revenue stood at $135.0 million in 2022, then surged by 31.91% to $178.1 million in 2023, then grew by 4.73% to $186.5 million in 2024, then retreated by 1.83% to $183.1 million in 2025, then fell by 6.52% to $171.2 million in 2026.
- Business Quant data shows AMPH's Revenue at $171.2 million in Q1 2026, $183.1 million in Q4 2025, and $191.8 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.65 Bn | 42.68 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.09 Bn | 39.44 Bn | 2.15 Bn | 4.14 Bn |
| 3 | Zoetis | 31.54 Bn | 29.86 Bn | 1.05 Bn | 2.47 Bn |
| 4 | Takeda Pharmaceutical | 28.61 Bn | 22.81 Bn | 5.10 Bn | 7.65 Bn |
| 5 | United Therapeutics | 22.11 Bn | 19.45 Bn | 683.80 Mn | 783.30 Mn |
| 6 | Viatris | 18.77 Bn | 17.88 Bn | 1.46 Bn | 3.76 Bn |
| 7 | Neurocrine Biosciences | 15.62 Bn | 15.23 Bn | 935.80 Mn | 959.00 Mn |
| 8 | Elanco Animal Health | 12.07 Bn | 11.54 Bn | 798.00 Mn | 1.37 Bn |
| 9 | Dr Reddys Laboratories | 10.09 Bn | 9.93 Bn | - | - |
| 10 | Amphastar Pharmaceuticals | 931.14 Mn | 641.02 Mn | 93.47 Mn | 183.90 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 183.90 Mn |
| Mar 31, 2026 | 171.17 Mn |
| Dec 31, 2025 | 183.11 Mn |
| Sep 30, 2025 | 191.84 Mn |
| Jun 30, 2025 | 174.41 Mn |
| Mar 31, 2025 | 170.53 Mn |
| Dec 31, 2024 | 186.52 Mn |
| Sep 30, 2024 | 191.21 Mn |
| Jun 30, 2024 | 182.39 Mn |
| Mar 31, 2024 | 171.84 Mn |
| Dec 31, 2023 | 178.11 Mn |
| Sep 30, 2023 | 180.56 Mn |
| Jun 30, 2023 | 145.71 Mn |
| Mar 31, 2023 | 140.02 Mn |
| Dec 31, 2022 | 135.02 Mn |
| Sep 30, 2022 | 120.13 Mn |
| Jun 30, 2022 | 123.47 Mn |
| Mar 31, 2022 | 120.37 Mn |
| Dec 31, 2021 | 120.89 Mn |
| Sep 30, 2021 | 112.20 Mn |